Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition
Journal of Proteome Research · 2025
DOI: 10.1021/acs.jproteome.5c00170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Enzhi Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, South Korea. Hauptthemen laut MEDLINE: Tamoxifen, Basic Helix-Loop-Helix Proteins, Drug Resistance, Neoplasm, Metabolomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, South Korea.
ORCID-Profile: Junjeong Choi
Förderung
- National Research Foundation of Korea
Zitieren
APA
Luo, E., Agarwal, N. M., & Choi, J. (2025). Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00170
Vancouver
Luo E, Agarwal NM, Choi J. Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00170
BibTeX
@article{Luo2025,
author = {Luo, Enzhi and Agarwal, Neeraj Manvi and Choi, Junjeong},
title = {Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition},
journal = {Journal of Proteome Research},
year = {2025},
doi = {10.1021/acs.jproteome.5c00170}
}
EUVIMED